From a U.S. trading perspective, here are the ways to play the strengthening dollar of 2015.» Read More
Bob Phillips, managing partner at Spectrum Management Group, and Peter Costa, president of Empire Executions and CNBC market analyst, told investors how to prepare their portfolios for the week ahead.
On Saturday, the House backed a health care bill that would expand coverage to nearly all Americans and bar insurance practices such as refusing to cover people with pre-existing medical conditions. How should investors be positioned? Bob Phillips, managing partner at Spectrum Management Group and Robert Zagunis, co-portfolio manager at Jensen Investment Management shared their insights.
Stocks finished mixed Tuesday as techs struggled after a downgrade on Intel. Transports rose following news that that Warren Buffett is buying Burlington Northern railroad. Industrials also gained after this week's encouraging manufacturing reports.
Stocks tumbled Tuesday, led by techs after an analyst downgrade on Intel. Transports rose following news that Warren Buffett is buying Burlington Northern railroad.
With the markets in volatility mode, investors will likely be focusing on the Federal Reserve Tuesday, even though the 2-day Federal Open Market Committee meeting that begins this afternoon won't conclude until Wednesday.
With $137 billion worth of brand name drugs going generic over the next several years, the recession and the looming threat of healthcare reform a lot of people have been running scared about what it all means for pharma. So, surprise, surprise! This morning IMS Health, which closely monitors the industry, came out with its annual forecast and it now says the American drug market is going to grow this year instead of shrink.
The trend for stocks continues to point up and could stay that way through the end of September, even if there are some choppy days.
The stock market took a rest Thursday, signaling traders that it may be getting ready to shake off some recent gains.
Rising stock prices are acting as a powerful magnet, prying loose fresh cash and drawing it into a market that's 58 percent above its March lows.
Wall Street's bulls are convinced there is enough good news to graze on for a while longer.
Dell's forecast that second half revenue should come in stronger than the first half are encouraging words for a stock market that has been doing little more than treading water this week.
It was quite a week to finish quite a month. The major averages were all up about 8% for the month of July and some of the economic news announced last week was even good enough to support the move.
Just off the lows of the day, futures point to a slightly lower open on this last trading day of the week. The markets are on pace for their fourth straight week of declines – their longest losing streak since February/March.
Unemployment hit 8.9 percent in April and some predict that number could climb to over 10 percent in 2009. But how far can this streamlining really go? See the S&P 500's leanest companies.
Unemployment hit 8.9 percent in April and some predict that number could climb over 10 percent in 2009 as major companies further streamline operations to combat the recession. While some industries are more labor intensive than others, employee productivity is a key measure that managers and investors look at when evaluating performance. Take a look at which companies are squeezing the most out their shrinking workforces.
Despite the continuing market rally, Rob Morgan of Clermont Wealth Strategies suggested that investors still remain cautious.
Despite the recession, Robert Doll, vice chairman of BlackRock, told CNBC’s investor audience that the health maintenance organizations (HMO) sector is “outperforming the market.”
Disney reported its fourth quarter and full year earnings after the bell Thursday, and Wall Street has been trying to sort out the economic impact on the media giant, which so far has performed much better than its peers through the downturn.
Cramer makes the call on viewers' favorite stocks.
AmerisourceBergen, one of the top U.S. drug wholesalers, said Thursday that quarterly earnings fell 28 percent as it took a write-down on its tetanus-diphtheria vaccine inventory.